Abstract
Neutralizing anti-tumor necrosis factor alpha (TNF-alpha) antibody treatment of mice infected with the neurotropic JHMV strain of mouse hepatitis virus showed no reduction of either virus-induced encephalomyelitis or central nervous system demyelination. TNF-alpha-positive cells were present in the central nervous system during infection; however, TNF-alpha could not be colocalized with JHMV-infected cells. In vitro, TNF-alpha mRNA rapidly accumulated following JHMV infection; however, no TNF-alpha was secreted because of inhibition of translation. Both live and UV-inactivated virus inhibited TNF-alpha secretion induced by lipopolysaccharide. These data show that TNF-alpha is not secreted from infected cells and indicate that if contributes to either JHMV-induced acute encephalomyelitis nor primary demyelination.
Publication types
-
Comparative Study
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Antibodies
-
Blotting, Western
-
Demyelinating Diseases / pathology
-
Demyelinating Diseases / physiopathology*
-
Demyelinating Diseases / virology
-
Encephalomyelitis / pathology
-
Encephalomyelitis / physiopathology*
-
Encephalomyelitis / virology
-
Gene Expression
-
Lipopolysaccharides / pharmacology
-
Macrophages / pathology
-
Macrophages / physiology
-
Macrophages / virology
-
Mice
-
Mice, Inbred BALB C
-
Mice, Inbred C57BL
-
Murine hepatitis virus / isolation & purification
-
Murine hepatitis virus / pathogenicity*
-
Murine hepatitis virus / radiation effects
-
RNA, Messenger / analysis
-
RNA, Messenger / biosynthesis
-
Species Specificity
-
Spinal Cord / pathology*
-
Spinal Cord / physiopathology
-
Spinal Cord / virology
-
Tumor Necrosis Factor-alpha / biosynthesis*
-
Ultraviolet Rays
Substances
-
Antibodies
-
Lipopolysaccharides
-
RNA, Messenger
-
Tumor Necrosis Factor-alpha